70 completed, 22 unknown, 14 recruiting, 8 terminated. 133 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 133 | Completed 70, Unknown 22, Recruiting 14, Terminated 8, Not yet recruiting 7, Withdrawn 7, Active not recruiting 4, Enrolling by invitation 1 |
Follow Spondylarthritis: new trials by email Literature Review of Spondylarthritis trials Research Report on Spondylarthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis Secukinumab (IL-17i ), Upadacitinib (JAKi) - Axial Spondyloarthritis (AxSpA) | Phase 4 | Not yet recruiting | The University of Texas Health Science Center, Houston | 40 | 2026-11-01 | 2026-10-14 |
| Ivarmacitinib With or Without Celecoxib for Ankylosing Spondylitis Ivarmacitinib with celecoxib, Ivarmacitinib Monotherapy - Ankylosing Spondylitis (AS) | Phase 4 | Not yet recruiting | Peking University Third Hospital | 138 | 2026-10-25 | 2026-10-27 |
| A Clinical Trial of Antiplatelets in Psoriasis Aspirin, Clopidogrel, Placebo - Psoriasis (PsO), Psoriatic Arthritis (PsA) | Phase 4 | Not yet recruiting | NYU Langone Health | 60 | 2026-09-01 | 2026-08-05 |
| A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically Breast Milk Sample Collection, Guselkumab - Psoriasis, Colitis, Ulcerative | Phase 4 | Recruiting | Janssen Research & Development, LLC | 10 | 2026-08-07 | 2026-11-03 |
| Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study) triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain | Phase 4 | Recruiting | Igor Wilderman. MD | 500 | 2026-07-30 | 2026-08-13 |
| Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease Deucravacitinib, Placebo - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | University of Texas Southwestern Medical Center | 128 | 2026-06-16 | 2026-09-01 |
| Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis Upadacitinib 15 MG [Rinvoq] - Axial Spondylarthritis (axSpA) | Phase 4 | Not yet recruiting | CARE ARTHRITIS LTD. | 200 | 2026-05-01 | 2026-02-06 |
| Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial GLP-1 agonists, Nutrition Counseling - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Medical College of Wisconsin | 22 | 2026-05-01 | 2026-11-05 |
| Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) Carotid Ultrasound, High-intensity lipid-lowering therapy, Standard care according to ESC 2021 guidelines - Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Instituto de Investigación Marqués de Valdecilla | 1944 | 2026-04-22 | 2026-11-10 |
| Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study Acemetacin - Axial Spondyloarthritis, Axial Spondyloarthritis, Non-Radiographic | Phase 4 | Not yet recruiting | Chinese PLA General Hospital | 150 | 2026-04-01 | 2026-05-12 |
| Preventing Structural Damage in Early Psoriatic Arthritis Amgevita 40Mg Solution for Injection, Methotrexate (Metoject® prefilled pen) - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Chinese University of Hong Kong | 108 | 2026-03-16 | 2026-03-23 |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases JAKi dose reduction strategy, JAKi disease activity guided continuation of same dose strategy - Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Sint Maartenskliniek | 200 | 2025-09-15 | 2025-09-17 |
| A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA) Guselkumab - Arthritis, Psoriatic | Phase 4 | Recruiting | Johnson & Johnson Private Limited | 100 | 2025-08-12 | 2026-08-28 |
| A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers Prescreen platform, biologics treatment - Psoriasis, Psoriasis Arthritis | Phase 4 | Recruiting | Taichung Veterans General Hospital | 50 | 2025-07-29 | 2025-09-02 |
| Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis Etanercept, Benzathine Penicillin, Placebo - Spondyloarthritis (SpA), Ankylosing Spondylitis (AS) | Phase 4 | Recruiting | Nanfang Hospital, Southern Medical University | 340 | 2025-06-14 | 2025-06-26 |
| A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) Tirzepatide - Psoriatic Arthritis, Overweight or Obesity | Phase 4 | Active not recruiting | Eli Lilly and Company | 200 | 2025-03-06 | 2026-09-21 |
| Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis Secukinumab, Adalimumab - Ankylosing Spondylitis | Phase 4 | Not yet recruiting | The Affiliated Hospital Of Guizhou Medical University | 10 | 2025-02-01 | 2025-02-18 |
| Vunakizumab in Adults with Spondyloarthritis vnacicizumab - Spondyloarthritis (SpA) | Phase 4 | Not yet recruiting | Sun Yat-sen University | 880 | 2025-01-10 | 2025-01-13 |
| Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases Shingrix, vaccination with 2 doses of Shingrix vaccine - Systemic Vasculitis, Spondylarthropathies | Phase 4 | Enrolling by invitation | Region Skane | 240 | 2024-12-17 | 2025-01-10 |
Showing 20 of 133. Sign in to see all of them.
Spondylitis, Ankylosing (59) · Arthritis, Psoriatic (48) · Axial Spondyloarthritis (18) · Arthritis, Rheumatoid (14) · Psoriasis (10) · Spondylarthropathies (9) · Arthritis (4) · Arthritis, Juvenile (4) · Crohn Disease (4) · Lupus Erythematosus, Systemic (4) · Systemic Vasculitis (4) · Non-Radiographic Axial Spondyloarthritis (3) · Scleroderma, Systemic (3) · Sjogren's Syndrome (3)
Bone Diseases (133) · Musculoskeletal Diseases (133) · Spinal Diseases (133) · Joint Diseases (132) · Spondylitis (131) · Arthritis (129) · Spondylarthropathies (111) · Ankylosis (74) · Axial Spondyloarthritis (56) · Skin and Connective Tissue Diseases (55) · Skin Diseases (49) · Skin Diseases, Papulosquamous (48) · Psoriasis (38) · Autoimmune Diseases (15)
Etanercept (32) · Adalimumab (23) · Infliximab (16) · secukinumab (13) · Methotrexate (9) · golimumab (9) · Celecoxib (6) · Sulfasalazine (6) · apremilast (5) · Certolizumab Pegol (4) · Tumor Necrosis Factor Inhibitors (4) · tofacitinib (4) · upadacitinib (4) · Diclofenac (3) · guselkumab (3)
Wyeth is now a wholly owned subsidiary of Pfizer (9) · Sun Yat-sen University (8) · Merck Sharp & Dohme LLC (7) · Chinese University of Hong Kong (6) · Pfizer (5) · Novartis Pharmaceuticals (4) · Amgen (3) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (3) · Charite University, Berlin, Germany (3) · Eli Lilly and Company (3) · Glostrup University Hospital, Copenhagen (3) · Nanfang Hospital, Southern Medical University (3) · Region Skane (3) · AbbVie (2) · CARE ARTHRITIS LTD. (2)
United States (23) · China (21) · Germany (20) · Denmark (16) · France (14) · Spain (12) · Netherlands (11) · Canada (10) · Poland (10) · United Kingdom (10) · Italy (9) · Sweden (9) · Czechia (8) · Finland (8) · Hungary (8)
Jieruo Gu, Prof (3) · Susanne J Pedersen, MD (3) · Edmund K Li, MD (2) · Lai Shan Tam, MD (2) · Walter Maksymowych, Dr. (2)
PMID 38488976, PMID 19740906, PMID 20124563, PMID 20511606, PMID 21317434, PMID 21341463, PMID 21540203, PMID 21551511, PMID 21630245, PMID 21639907, PMID 21700683, PMID 21834061, PMID 21859696, PMID 22006544, PMID 22035157, PMID 22089462, PMID 22127697, PMID 22298793, PMID 22337244, PMID 22653382, PMID 22824238, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23123020, PMID 23286772, PMID 23525305, PMID 23818263, PMID 23981683, PMID 24286269, PMID 24369412, PMID 24501241, PMID 24861696, PMID 24961747, PMID 25428762, PMID 25535650, PMID 25656734, PMID 25913550, PMID 25986458, PMID 26242443, PMID 26414004, PMID 26568588, PMID 27449221, PMID 28502609, PMID 28601821, PMID 28619118, PMID 28785857, PMID 28968874, PMID 29556419
2015 (5), 2016 (4), 2023 (3), 2005 (2), 2017 (2), 2018 (2), 2025 (2), 2009 (1), 2014 (1), K23HL152013 (1)